Hatteras’ mission is to create transformative healthcare companies in the research-driven, undercapitalized regions of the Southeast and Mid-Atlantic. Over half of our portfolio companies were created with our initial investment.

At Hatteras Venture Partners, we believe that breakthrough science and entrepreneurial innovation have the power to create valuable new ways of treating and diagnosing disease, providing value for our investors and transforming human health.

The Hatteras team brings operational experience, a renowned strategic partner network, and a successful investment track record. We are passionate about utilizing our backgrounds to engage entrepreneurs and enhance the value of their companies.

Portfolio

Latest News

Tumor Ablation Expert Dr. Fred Lee, Jr. Joins HistoSonics as Board Member, Senior Medical Advisor

September 14, 2016

Will Help Advance HistoSonics’ Non-Invasive Therapy Technology in Liver Tumors, Other High-Value Applications Ann Arbor, MI – September 13, 2016 – HistoSonics, Inc. (http://www.histosonics.com ) (the “Company”) announced today that…

More News